Friday, June 20, 2014

New York Passes Medical Marijuana Law

New York is the latest state to legalize medical marijuana . The State senate today passed a bill allowing the drug. The drug will be passed in a non-smokable variety.


The New York state senate voted 49-10 to approve the bill, which would authorize marijuana for therapeutic purposes for patients with serious diseases or conditions like cancer, AIDS and epilepsy. The Assembly approved the bill around 2:45 a.m. Friday, and Gov. Andrew Cuomo has already pledged his support.
The Senate debated the measure for more than two hours Friday, where some senators passionately urged their colleagues to help patients and support the bill while others raised concerns about putting faith in the state Department of Health to regulate the program.
As lawmakers voted, advocates for medical marijuana — including parents with their young, epileptic children — watched from a gallery above the chamber floor, applauding loudly as Senate clerk announced the final vote.
"We can try to tweak a bill forever, and we can be here not passing any legislation because we don't have a perfect bill," said Sen. Ted O'Brien, D-Irondequoit, Monroe County. "But the fact of the matter for me remains this: People are suffering right now. That suffering can be alleviated as soon as we make this available to them."
The bill would require the state to have its medical-marijuana program up and running within 18 months. It would expire after seven years, though Cuomo could suspend the program at any time if State Police of the Department of Health find it is being abused.
Patients would not be able to smoke the drug, though vaporizing and oil-based cannabis extracts would be authorized. It grants broad authority to the state health commissioner to oversee the system and certify doctors who can prescribe the drug.
Sen. Thomas Libous, R-Binghamton, delivered an emotional speech on the Senate floor, recalling his own battle with prostate and lung cancer and chemotherapy treatments, which he receives at Memorial Sloan Kettering Cancer Center in Manhattan.
Libous, who has said he would likely try medical marijuana if it is legalized and recommended by his doctor, said he had concerns about offering "false hope" to patients looking for a cure. He said he couldn't support the bill because of concerns over whether it can be handled by the Department of Health, which he called "one of the biggest bureaucracies in the state."
Sen. William Larkin, R-New Windsor, Orange County, was cheered by advocates after delivering a fiery five-minute speech in favor of the bill, saying he "doesn't give a damn" about who supports him, but rather about doing what he believes is right. The 86-year-old senator, whose district extends into northern Rockland County, said he was swayed by parents of children with epilepsy, which has responded favorably to certain oil-based cannabis extracts.
"We can talk about the moon and the sun and everything else," Larkin said. "But the bottom line is, remember this: Lead or get the hell out of the way."
When signed by Cuomo, New York will become the 23rd state to approve medical marijuana in some form, according to the Drug Policy Alliance. Several other states, like Utah and Florida, have approved cannabidiol, a cannabis extract, for medical purposes.

Paddy Deighan, J.D. Ph.D

Wednesday, June 18, 2014

Medical Cannabis Industry Overview

Many people wrongly believe that the medical cannabis industry is a cottage industry that is run by lightly trained people who are more hobbyists than scientist.  This is perception but it is the polar opposite of reality. There is a massive amount of talented scientific minds working in this space. 

The science and medicine is first rate.  The future of this industry is limitless. The science and testing indicate that medical cannabis has a staggering number of applications.  It is especially interesting to note that the range of medical conditions and anomalies is endless. 

The general public and most of the medical community do not realize that medical cannabis supplies treatment options for conditions that have few medical options. migraine headaches is an example.  Most treatment options are some variation of caffeine and aspirin.  Sometimes this works. However, it is not a systemic and sustainable.  Medical cannabis has proven to be a viable and efficacious solution.  I personally know two migraine headache sufferers who are ecstatic with the results of a CBD based product.


Medical cannabis is also proving useful in the anxiety and pain aspects of healthcare.  The early results are very promising.  Medical cannabis has the potential to be a cost effective and efficacious alternative to a lot of traditional, medical options.  Medical marijuana, CBD based products / cannabis will be the next huge waive of treatment options in the United States. Other countries already know the value of these products. The USA is only beginning to realize the potential for this industry.

This industry is in its infancy.  With the medical and scientific resources focused on this space, the future is promising.

Paddy Deighan J.D. Ph.D

Monday, June 16, 2014

Welcome to Cannabinoid Partners

We are the first and pre-eminent partners for the medical cannabis industry.  Cannabinoid Partners has established proprietary methods to optimize and distribute medical cannabis products and services.  Our collective experience in medicine, science, law and distribution is unsurpassed. 

Cannabinoid Partners has established a network of US physicians. The network consists of physicians from many specialties such as pain medicine, dermatology, plastic surgery, anti-aging and other specialties. Virtually all uses for medical cannabis are represented in our network. 

Cannabinoid Partners has also developed ancillary relationships with other business entities to aid and support the medical cannabis industry. Our scope is international. 

Everyone is aware of the medical and financial benefits of this "budding" industry. However, few, if any, have determined how to monetize the opportunity.  Cannabinoid Partners recognize the challenges and we see the opportunity. Accordingly, we have spent tremendous time, energy and monetary resources to provide a vehicle for legitimate medical cannabis products and services. Very few businesses are able to navigate the legal and scientific minefield that challenges the medical cannabis industry.



A recent article by the Huffington Post illustrates the frustration that many have in this industry.

Come see us at the International Cannabinoid Research Society meeting in Baveno, Italy from June 28th to July 2nd.  We would be happy to assist you in pursuit of your goals. We have fee based solutions as well as cooperative methodologies in order to best service your needs.  Look for Dr. Deighan at the Hotel Splendid in Baveno.

Paddy Deighan, J.D. Ph.D